• Addictive Substances and Sleep: How Alcohol, Opioids, and Cannabis Affect Sleep
• Addiction, Overdose, and Suicide: Preventing Deaths From Drug Self-Intoxication
• Buprenorphine Update and Evolving Standards of Care
• Clearing the Smoke: Cannabis and Mental Health Effects Part I
• Clearing the Smoke: Cannabis and Mental Health Effects Part II
• Evidence-Based Treatment of Alcohol Use Disorder
• Expanding Access To Medication Assisted Treatment for Opioid Use Disorders to Patients in the Hospital
• Introduction to Complementary, Alternative, and Integrative Medicine in Psychiatry
• Medical Cannabis: What Every Psychiatrist Should Know
• Medication Assisted Treatment in the Emergency Room Setting
• Modeling Mood and Emotional Patterns from Speech in Bipolar Disorder
• Motivational Interviewing: Brushing up on the Basics
• Motivational Interviewing for Clinical Practice
• Office-Based Buprenorphine Treatment of Opioid Use Disorder
• Pain and Addiction: A Clinical Path To Mindfulness
• Preclinical Development of Ketamine and the Metabolite 26-6r-Hydroxynorketamine for Depression and Other Disorders
• Primary Care for Psychiatrists: Addressing Health Disparities Among People with Serious Mental Illness
• Recovery Support for Young People with Opioid Use Disorders
• The Classification of Personality Disorders – New Developments
• The X:BOT Trial: XR-Naltrexone vs. Buprenorphine-Naloxone Film
• Updates in Women's Health: Depression and Anxiety During Pregnancy and Postpartum
• Vaccines for Opioid Use Disorder: Focusing on the Fentanyl Epidemic
• What Should Psychiatrists Know and Do About Gun Violence Among America's Adolescents and Emerging Adults